DNA methylation is an epigenetic modification in humans that controls gene expression, and also enables genomic imprinting.Increasing Prevalence of Cancer Cases Expected to Spur the Growth of the Global DNA Methylation Market
Global DNA Methylation Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global DNA Methylation market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
Market Opportunities
According to this research report titled “Global DNA Methylation Market Analysis, 2020”, the Global DNA Methylation market is anticipated to grow at a considerable CAGR during 2020-25F. The growth of the market is attributed to an increasing burden of cancer, diabetes, and mental disorders worldwide, along with rising degree of funding toward research and development of innovative products and launch of various DNA methylation start-ups globally.
Market Segmentation
Clinical Application Acquired Significant Market Share
Based on application, clinical application acquired significant market share in the Global DNA Methylation market in 2019 on account of early detection of cancer which further helps in decision-making process for disease diagnosis, prognosis, and treatment. The clinical application of methylation biomarkers of DNA developing rapidly into a competitive scientific field as it is used to predict response to chemotherapy strategies. Hence, this is projected to upsurge the growth of the market in the near future as stated in the research report “Global DNA Methylation Market Analysis, 2020”.
Competitive Landscape
According to the publisher, the key players with a considerable market share in the Global DNA Methylation market include Abcam PLC, Active Motif, Inc, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Diagenode Diagnostics S.A., EpiGentek Group Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, New England Biolabs, Inc., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Thermo Fisher Scientific Inc., Zymo Research Corporation, etc.
Key Questions Answered in the Market Research Report:
1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global DNA Methylation Market?
2. What is the region wise industry size, growth drivers and challenges key market trends?
3. What are the key innovations, technology upgrades, opportunities, regulations in the Global DNA Methylation Market?
4. Who are the key competitors or market players and how they perform in Global DNA Methylation Market based on competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the course of Global DNA Methylation Market study?
Table of Contents
1. Introduction
5. Global DNA Methylation Market Analysis, 2018-2025F
6. North America DNA Methylation Market Analysis, 2018-2025F
7. South America DNA Methylation Market Analysis, 2018-2025F
8. Europe DNA Methylation Market Analysis, 2018-2025F
9. Middle East & Africa DNA Methylation Market Analysis, 2018-2025F
10. Asia Pacific DNA Methylation Market Analysis, 2018-2025F
11. Global DNA Methylation Market Regulations, Policies, Product Benchmarks
13. Global DNA Methylation Market Dynamics
15. Global DNA Methylation Market, Competition Outlook
Companies Mentioned
- Abcam PLC
- Active Motif Inc
- Agilent Technologies Inc
- Bio-Rad Laboratories Inc.
- Diagenode Diagnostics S.A.
- EpiGentek Group Inc.
- Exact Sciences Corporation
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Merck KGaA
- New England Biolabs Inc.
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
- Zymo Research Corporation
Methodology
LOADING...